In millions, except per share items | Jun-30-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 |
| 10-Q | 8-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q |
Interest income: |
Interest income on loans | | | 634.0 | 618.6 | 619.3 | 616.4 | 599.6 | 585.1 |
Interest income on investments | | | 257.4 | 241.0 | 225.9 | 216.1 | 210.1 | 206.0 |
Interest income on repurchase agreements | | | 10.6 | 9.7 | 10.0 | 10.3 | 10.2 | 9.2 |
| | | 913.3 | 877.3 | 861.5 | 847.2 | 822.9 | 803.1 |
Interest expense: |
Interest on deposits | | | 34.7 | 25.8 | 26.4 | 28.1 | 30.6 | 35.3 |
| | | 54.5 | 45.6 | 46.0 | 47.6 | 48.7 | 51.7 |
Net interest income | | | 899.7 | 831.8 | 815.5 | 799.6 | 774.2 | 751.4 |
Provision for loan losses | | | 10.4 | 21.0 | 20.0 | 16.5 | 37.5 | 35.0 |
Net interest income after provision for loan losses | | | 889.3 | 810.8 | 795.5 | 783.1 | 736.7 | 716.4 |
Deposit and loan fees | | | | 88.7 | 86.1 | 84.5 | 84.3 | 80.8 |
Other non-interest income | | | 460.6 | 393.2 | 381.1 | 492.2 | 497.5 | 489.9 |
Total non-interest income | | | 526.7 | 482.0 | 467.2 | 576.7 | 581.8 | 570.6 |
Non-interest expenses | | | 860.3 | 847.5 | 833.6 | 838.0 | 827.1 | 834.3 |
Pre-tax income before non-recurring items | | | 548.2 | 478.8 | 461.5 | 553.5 | 522.7 | 482.1 |
Non-recurring items | | | 36.7 | 33.6 | 32.4 | 31.7 | 31.3 | 29.4 |
Pre-tax income | | | 511.5 | 445.2 | 429.1 | 521.8 | 491.4 | 452.7 |
Income taxes | | | 95.0 | 78.9 | 76.0 | 91.0 | 81.9 | 70.1 |
Tax rate | | | 18.6% | 17.7% | 17.7% | 17.4% | 16.7% | 15.5% |
Net income | | | 416.5 | 366.3 | 353.0 | 430.8 | 409.5 | 382.6 |
Net margin | | | 29.4% | 28.3% | 28.0% | 31.7% | 31.1% | 29.7% |
|
Basic EPS | | | $8.62 | $7.58 | $7.32 | $8.94 | $8.51 | $7.96 |
Diluted EPS | | | $8.54 | $7.51 | $7.25 | $8.87 | $8.46 | $7.93 |
|
Shares outstanding (basic) | | | 48.3 | 48.3 | 48.2 | 48.2 | 48.1 | 48.0 |
Shares outstanding (diluted) | | | 48.7 | 48.8 | 48.7 | 48.6 | 48.4 | 48.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |